Clinical Trial Update: The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of an angiotensin receptor-neprilysin inhibitor on cardiac fibrosis in patients with heart failure with preserve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Chongqing Medical University | Conditions: Heart Failure With Preserved Ejection Fraction | Phase 2 | Status: UNKNOWN